BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:REGN20423 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of REGN20423\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07527923-1471@assetmemo.bio
DTSTAMP:20261121T005813Z
DTSTART;VALUE=DATE:20280814
DTEND;VALUE=DATE:20280815
SUMMARY:REGN20423: Phase 1 readout est. (NCT07527923)
DESCRIPTION:REGN20423\, phase 1\, Atopic Dermatitis.\nStudy: First-in-Human
  Trial to Assess REGN20423 in Healthy Adult Participants and Adult Partici
 pants With Atopic Dermatitis\nEstimated primary completion: 14 August 2028
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/regn20423#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT07527923
URL:https://assetmemo.bio/drug/regn20423#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
